The decriminalization of illicit drugs in British Columbia: a national evaluation protocol

This evaluation will draw on implementation science research practices to evaluate and understand the full impacts of this novel drug policy experiment. Results will be widely disseminated through manuscripts, reports, presentations, and infographics, which will be adapted and tailored for specific audiences. The protocol identifies several anticipated challenges and limitations. This evaluation's evidence-based findings will be poised to offer pivotal insights that can shape and refine the discourse on drug policy and will serve as a critical resource for understanding the multifaceted impacts of decriminalization.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2024-10-18
DOI
https://doi.org/10.1186/s12889-024-20336-9
Citations
13
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
7.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The decriminalization of illicit drugs in British Columbia: a national evaluation protocol

Matthew Hickman, Farihah Ali, Jessica Xavier, Louisa Degenhardt et al.
13 citations
BMC Public Health
Opioid Use Disorder Treatment
7.06
article

The decriminalization of illicit drugs in British Columbia: a national evaluation protocol

Matthew Hickman, Farihah Ali, Jessica Xavier, Louisa Degenhardt, J Costello, Tara Elton‐Marshall, Laura MacKinnon, Amanda Butler, Sarah Ferencz, Paul Griffiths, Frank Crichlow, João Goulão, Jean‐François Crépault, Kate Alison Hodgson, David C. Hodgins, Alissa Greer, Elaine Hyshka, Sherry H. Stewart, Tara Gomes, Dan Werb, Jürgen T. Rehm, Julie Bruneau, Jade Boyd, Kali-olt Sedgemore, Sameer Imtiaz, Bernard Le Foll, Matthew Bonn, Geoff Bardwell, Sanjana Mitra, Kurt Lock, Cayley Russell, Rita Shahin, Sean Patenaude, Wayne M. Smith, Rennie Linklater, Taija McLuckie, Michael Nurse
article en
13 citations

Abstract

This evaluation will draw on implementation science research practices to evaluate and understand the full impacts of this novel drug policy experiment. Results will be widely disseminated through manuscripts, reports, presentations, and infographics, which will be adapted and tailored for specific audiences. The protocol identifies several anticipated challenges and limitations. This evaluation's evidence-based findings will be poised to offer pivotal insights that can shape and refine the discourse on drug policy and will serve as a critical resource for understanding the multifaceted impacts of decriminalization.

BMC Public HealthVol. 24(1)
Centre for Addiction and Mental Health (CA), Universität Hamburg (DE), Simon Fraser University (CA), University of Toronto (CA), Canadian Centre on Substance Use and Addiction (CA), Canada Research Chairs (CA), University Medical Center Hamburg-Eppendorf (DE)
Canadian Institutes of Health Research
Peace, Justice and strong institutions, Reduced inequalities
Openalex Percentile: Top 2%
Opioid Use Disorder Treatment
7.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.